Pasar al contenido principal

OPTIMIZACION DE LA ADMINISTRACION TOPICA DE FARMACOS MEDIANTE HERRAMIENTAS NO INVASIVAS

PID2020-114530GA-I00

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2020
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario UNIVERSITAT DE VALÈNCIA

Resultados relacionados

Resultados totales (Incluyendo duplicados): 2
Encontrada(s) 1 página(s)

RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Cyclosporin A-loaded dissolving microneedles for dermatitis therapy: Development, characterisation and efficacy in a delayed-type hypersensitivity in vivo model

  • Martínez-Navarrete, Miquel
  • Guillot, Antonio Jose
  • Lobita, Maria C.
  • Recio, Maria Carmen
  • Giner, Rosa
  • Aparicio-Blanco, Juan
  • Montesinos-Mezquita, María Carmen
  • Santos, Helder A.
  • Melero, Ana
[EN] Several drugs can be used for treating inflammatory skin pathologies like dermatitis and psoriasis. However, for the management of chronic and long-term cases, topical administration is preferred over oral delivery since it prevents certain issues due to systemic side effects from occurring. Cyclosporin A (CsA) has been used for this purpose; however, its high molecular weight (1202 Da) restricts the diffusion through the skin structure. Here, we developed a nano-in-micro device combining lipid vesicles (LVs) and dissolving microneedle array patches (DMAPs) for targeted skin delivery. CsA-LVs allowed the effective incorporation of CsA in the hydrophilic DMAP matrix despite the hydrophobicity of the drug. Polymeric matrix composed of poly (vinyl alcohol) (5% w/v), poly (vinyl pyrrolidine) (15% w/v) and CsA-LV dispersion (10% v/v) led to the formation of CsA-LVs@DMAPs with adequate mechanical properties to penetrate the stratum corneum barrier. The safety and biocompatibility were ensured in an in vitro viability test using HaCaT keratinocytes and L929 fibroblast cell lines. Ex vivo permeability studies in a Franz-diffusion cell setup showed effective drug retention in the skin structure. Finally, CsA-LVs@DMAPs were challenged in an in vivo murine model of delayed-type hypersensitivity to corroborate their potential to ameliorate skin inflammatory conditions. Different findings like photon emission reduction in bioluminescence study, normalisation of histological damage and decrease of inflammatory cytokines point out the effectivity of CsA-LVs@DMAPs to treat these conditions. Overall, our study demonstrates that CsA-LVs@DMAPs can downregulate the skin inflammatory environment which paves the way for their clinical translation and their use as an alternative to corticosteroid-based therapies., Open Access funding provided thanks to the CRUE-CSIC agreement with Springer Nature. This publication is part of the grants PID2020-114530GA-I00 (to A.M.) and PID2021-124890OB-I00 (to M.C.M.) funded by MCIN/AEI/10.13039/501100011033 and by "ERDF A way of making Europe", by the "European Union". H.A.S. acknowledges financial support from the UMCG Research Funds and the Academy of Finland (grant no. 331151). M.M-N acknowledges the financial support from ACIF grant funded by Generalitat Valenciana; Conselleria d'Innovacio, Universitats, Ciencia i Societat Digital (ref: CIACIF/2022/341). A.J.G. acknowledges the financial support from "Margarita Salas" grant (ref: MS21-126) funded by the Spanish Ministry of Universities and European Union (Next generation-EU).
RiuNet. Repositorio Institucional de la Universitat Politécnica de Valéncia
Publicación Artículo científico (JournalArticle)

Dissolving Microneedle Array Patches Manufactured By Solvent Casting Technique and Essential Characterization of Microneedle-Based Biomedical Devices

  • Guillott, Antonio Jose
  • Bernabeu-Martínez, José Alejandro
  • Martínez-Navarrete, Miquel
  • Rubio-Lopezt, Miguel Angel
  • Melero, Ana
[EN] Microneedle-based technology has revolutionized the field of skin and transdermal delivery research and is considered nowadays as the most straightforward approach to administering drugs through the skin. Microneedle Array Patches (MAPs) success is mainly due to their ability to nullify the skin barrier function that opposes the entrance of topically applied drugs by painless piercing the stratum corneum layer. Dissolving MAPs (DMAPs) stand out among other MAPs-based device types due to the biocompatibility of their constituent materials, the possibility of self-administration by patients, and the absence of sharp waste generated after use. DMAPs are usually made of polymeric materials that redisperse upon insertion into the skin when in touch with interstitial fluids, releasing their cargo. At the bench level, DMAPs are commonly manufactured using the solvent casting method, which involves the use of negative master molds of the desired MAPs shape and length, onto which drug-loaded polymeric dispersions are cast. They are subsequently forced to fill the mold's cavities by the application of a centrifugal force or positive pressure. After drying, DMAPs become solid and are peeled off from the master molds, and they routinely undergo various characterization studies before use. These assays typically comprise the study of the mechanical properties of DMAPs, determination of residual water content, ex vivo capacity to penetrate the skin structure, drug release performance, and in vitro assessment of biocompatibility., This publication is part of the grant PID2020-114530GA-I00 funded by MCIN/AEI/10.13039/501100011033.